Literature DB >> 3049690

Pemphigoid and ulcerative colitis.

J H Barth1, S E Kelly, F Wojnarowska, J A Savin, S Whittaker, J J Cream, J E White.   

Abstract

We report eight patients with ulcerative colitis who have subsequently developed pemphigoid. Four patients were investigated to determine the pattern of pemphigoid antibody staining on whole and chemically split skin and oral mucosa to distinguish between pemphigoid and epidermolysis bullosa acquisita. The findings were suggestive of pemphigoid with a predominantly epidermal pattern. Three patients were studied for the presence of antibodies against the colon (which were absent). The relationship between pemphigoid and ulcerative colitis is discussed in relation to a case-control study.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3049690     DOI: 10.1016/s0190-9622(88)70176-0

Source DB:  PubMed          Journal:  J Am Acad Dermatol        ISSN: 0190-9622            Impact factor:   11.527


  5 in total

1.  Linear IgA bullous dermatosis: an association with ulcerative colitis versus renal cell carcinoma.

Authors:  A Scott Keller; Molly B Bouldin; Lisa A Drage; Stephen C Hauser; Mark D P Davis
Journal:  Dig Dis Sci       Date:  2003-04       Impact factor: 3.199

2.  The association of bullous pemphigoid and ulcerative colitis.

Authors:  Lisbeth Selby; Fernando De Castro; Willem J S De Villiers
Journal:  Dig Dis Sci       Date:  2004 Nov-Dec       Impact factor: 3.199

Review 3.  Bullous pemphigoid: from bench to bedside.

Authors:  Scott R A Walsh; David Hogg; P Régine Mydlarski
Journal:  Drugs       Date:  2005       Impact factor: 9.546

4.  Ulcerative colitis associated with Weber-Christian panniculitis and musculitis: a case report.

Authors:  M Nozue; A Ono; N Goto
Journal:  J Gastroenterol       Date:  1994-02       Impact factor: 7.527

Review 5.  Insights Into the Pathogenesis of Bullous Pemphigoid: The Role of Complement-Independent Mechanisms.

Authors:  Connor Cole; Keshavamurthy Vinay; Luca Borradori; Kyle T Amber
Journal:  Front Immunol       Date:  2022-07-07       Impact factor: 8.786

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.